KR970702865A - 신규 카르바페넴 유도체(Novel Carbapenem Derivatives) - Google Patents

신규 카르바페넴 유도체(Novel Carbapenem Derivatives)

Info

Publication number
KR970702865A
KR970702865A KR1019960706355A KR19960706355A KR970702865A KR 970702865 A KR970702865 A KR 970702865A KR 1019960706355 A KR1019960706355 A KR 1019960706355A KR 19960706355 A KR19960706355 A KR 19960706355A KR 970702865 A KR970702865 A KR 970702865A
Authority
KR
South Korea
Prior art keywords
carbapenem derivatives
novel carbapenem
novel
derivatives
carbapenem
Prior art date
Application number
KR1019960706355A
Other languages
English (en)
Other versions
KR100231496B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR970702865A publication Critical patent/KR970702865A/ko
Application granted granted Critical
Publication of KR100231496B1 publication Critical patent/KR100231496B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/40—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by an aliphatic carboxylic acid, which is substituted by hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019960706355A 1995-03-10 1996-03-08 신규 카르바페넴 유도체 KR100231496B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP95-51616 1995-03-10
JP5161695 1995-03-10
PCT/JP1996/000573 WO1996028455A1 (fr) 1995-03-10 1996-03-08 Nouveaux derives de carbapeneme

Publications (2)

Publication Number Publication Date
KR970702865A true KR970702865A (ko) 1997-06-10
KR100231496B1 KR100231496B1 (ko) 1999-11-15

Family

ID=12891830

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960706355A KR100231496B1 (ko) 1995-03-10 1996-03-08 신규 카르바페넴 유도체

Country Status (9)

Country Link
US (1) US5990101A (ko)
EP (1) EP0760370B1 (ko)
KR (1) KR100231496B1 (ko)
CN (1) CN1057091C (ko)
CA (1) CA2189995C (ko)
DE (1) DE69622801T2 (ko)
ES (1) ES2179932T3 (ko)
TW (1) TW425396B (ko)
WO (1) WO1996028455A1 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW445265B (en) * 1996-11-25 2001-07-11 Meiji Seika Kaisha Carbapenem derivatives and antimicrobial agents
KR20000070347A (ko) * 1997-01-28 2000-11-25 이치로 키타사토 신규한 카바페넴 유도체
WO1999009032A1 (en) * 1997-08-13 1999-02-25 Merck & Co., Inc. Carbapenems with naphthosultam derivative linked via methylene
EP1104424B1 (en) 1998-06-17 2004-04-07 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates
US6458780B1 (en) 1998-07-27 2002-10-01 Meiji Seika Kaisha, Ltd. Carbapenem derivatives
JP2005231997A (ja) * 2000-01-24 2005-09-02 Meiji Seika Kaisha Ltd カルバペネム誘導体の製造法
EP1251133B1 (en) * 2000-01-26 2004-10-13 Meiji Seika Kaisha Ltd. Novel carbapenem derivatives
WO2001055155A1 (fr) * 2000-01-26 2001-08-02 Meiji Seika Kaisha, Ltd. Nouveaux derives de carbapenem de type sel quaternaire
ES2371165T3 (es) * 2003-06-18 2011-12-28 Meiji Seika Pharma Co., Ltd. Intermediario cristalino de carbapenemo.
US11267824B2 (en) * 2017-08-17 2022-03-08 Idorsia Pharmaceuticals Ltd Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
JPS6261985A (ja) * 1985-09-11 1987-03-18 Sankyo Co Ltd カルバペネム化合物およびその製法
JPH075607B2 (ja) * 1990-10-12 1995-01-25 日本レダリー株式会社 カルバペネム化合物の製造法
JPH05230573A (ja) * 1992-02-25 1993-09-07 Furukawa Alum Co Ltd 耐食性および強度に優れたアルミニウム合金製ブレージングシート
JPH06211908A (ja) * 1992-11-30 1994-08-02 Shin Etsu Chem Co Ltd 塩化ビニル系重合体の製造方法
DE69424524T2 (de) * 1993-09-16 2000-12-21 Meiji Seika Co Neue cephem-derivate

Also Published As

Publication number Publication date
US5990101A (en) 1999-11-23
ES2179932T3 (es) 2003-02-01
DE69622801D1 (de) 2002-09-12
EP0760370A1 (en) 1997-03-05
WO1996028455A1 (fr) 1996-09-19
CA2189995C (en) 2001-01-23
EP0760370B1 (en) 2002-08-07
CN1057091C (zh) 2000-10-04
DE69622801T2 (de) 2003-03-27
CA2189995A1 (en) 1996-09-19
TW425396B (en) 2001-03-11
KR100231496B1 (ko) 1999-11-15
EP0760370A4 (en) 1997-05-28
CN1148390A (zh) 1997-04-23

Similar Documents

Publication Publication Date Title
DE69611361T2 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
NO974103L (no) Arylsulfonylaminohydroksamsyre-derivater
DE69610698T2 (de) Chinazolin-derivate
PT833828E (pt) Derivados de rapamicina
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9609320A (pt) Cianofeniluracilas substituidas
NO964667D0 (no) Purin-6-on-derivater
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
DE69628200D1 (de) Diarylalkenylamin-derivate
DE69627830D1 (de) Pyrazol-derivate
KR970702865A (ko) 신규 카르바페넴 유도체(Novel Carbapenem Derivatives)
BR9608890A (pt) N-metilenotiouréias substituídas
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
DK0843675T3 (da) Aza-anthracyclinonderivater
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
ATE202088T1 (de) 4-mercapto-benzoylguanidin-derivate
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
DE69620514T2 (de) 5-aminoflavon-derivate

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Publication of correction
FPAY Annual fee payment

Payment date: 20040823

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee